Avenna at NOAH Conference

In our presentation at this renowned tech conference, our CEO discusses the burden of chronic inflammatory diseases (CIDs) and limitations in CIDs diagnostic procedures. . Additionally, this presentation explains how Avenna medical technology aims to reliably detect and predict future CIDs using molecular signals from blood samples.